Aguirre G, Raber I, Yanoff M, Haskins M
Scheie Eye Institute, School of Veterinary Medicine, University of Pennsylvania, Philadelphia 19104.
Invest Ophthalmol Vis Sci. 1992 Aug;33(9):2702-13.
This report contains the results of studies designed to evaluate corneal clearing in mucopolysaccharidosis VI (MPS VI)-affected cats. Corneal buttons from affected cats were transplanted into normal cat corneas and, as controls, normal-to-normal and normal-to-affected transplants also were done. No clearing of the MPS VI graft or host beds occurred, nor was there any clouding of the normal donor or recipient corneal tissues. This assessment was made by serial clinical examinations over a 14-30 mo period and by light and electron microscopic examination of the corneal tissues at the end of the study. Lack of corneal clearing under conditions that would maximize such a process in this animal model indicates that corneal clearing is not an appropriate index for measuring the success of systemic therapy in MPS VI.
本报告包含旨在评估黏多糖贮积症VI型(MPS VI)患猫角膜透明度的研究结果。将患猫的角膜移植片移植到正常猫的角膜中,作为对照,还进行了正常猫之间以及正常猫与患猫之间的角膜移植。MPS VI移植片或宿主植床均未出现透明度增加,正常供体或受体角膜组织也未出现混浊。这一评估是通过在14 - 30个月期间进行的系列临床检查以及在研究结束时对角膜组织进行光镜和电镜检查得出的。在该动物模型中,在能使这一过程最大化的条件下缺乏角膜透明度增加,表明角膜透明度增加并非衡量MPS VI全身治疗成功与否的合适指标。